Bioequivalence of Amoxicillin and Clavulanic Acid 250 mg/62.5 mg/5 mL Powder for Oral Suspension versus Augmentin® Forte 250 mg/62.5 mg/5 mL Powder for Oral Suspension in Healthy Participants Under Fed Conditions
BLCL-AMC-03
Phase 1 other active
Quick answer
Bioequivalence of Amoxicillin and Clavulanic Acid 250 mg/62.5 mg/5 mL Powder for Oral Suspension versus Augmentin® Forte 250 mg/62.5 mg/5 mL Powder for Oral Suspension in Healthy Participants Under Fed Conditions for No medical condition. is a Phase 1 program (other) at BIAL - Portela & Ca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIAL - Portela & Ca
- Indication
- No medical condition.
- Phase
- Phase 1
- Modality
- other
- Status
- active